Biocon shares gain 3% as arm Syngene gets Sebi nod for IPO
The company had filed its draft red herring prospectus (DRHP) with Sebi through its lead merchant banker Axis Capital in April.
By PTI | Updated:
MUMBAI: Shares of biotechnology major Biocon gained 3 per cent today after its research arm Syngene International received capital markets regulator Sebi's approval to launch an initial public offer (IPO).
Biocon stock climbed 2.93 per cent to Rs 460 on the BSE. On the NSE, it was up 3 per cent to Rs 460.
The company had filed its draft red herring prospectus ( DRHP) with Sebi through its lead merchant banker Axis Capital in April.
Biocon stock climbed 2.93 per cent to Rs 460 on the BSE. On the NSE, it was up 3 per cent to Rs 460.
The company had filed its draft red herring prospectus ( DRHP) with Sebi through its lead merchant banker Axis Capital in April.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
SBI Funds Management gets Sebi nod for IPOADVERTISEMENT
